These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31134153)

  • 1. Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study.
    Wang Q; Xu M; Sun Y; Chen J; Chen C; Qian C; Chen Y; Cao L; Xu Q; Du X; Yang W
    Front Oncol; 2019; 9():354. PubMed ID: 31134153
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinct Gene Expression Profiles of Matched Primary and Metastatic Triple-Negative Breast Cancers.
    Kaur J; Chandrashekar DS; Varga Z; Sobottka B; Janssen E; Kowalski J; Kiraz U; Varambally S; Aneja R
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse.
    Siddappa CM; Pillai SG; Snider J; Alldredge P; Trinkaus K; Watson MA; Aft R
    Breast Cancer Res Treat; 2019 Nov; 178(2):317-325. PubMed ID: 31432366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
    Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
    Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an immune-related genes nomogram for the preoperative prediction of axillary lymph node metastasis in triple-negative breast cancer.
    Tan W; Xie X; Huang Z; Chen L; Tang W; Zhu R; Ye X; Zhang X; Pan L; Gao J; Tang H; Zheng W
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):288-297. PubMed ID: 31858816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer.
    Thangavel H; De Angelis C; Vasaikar S; Bhat R; Jolly MK; Nagi C; Creighton CJ; Chen F; Dobrolecki LE; George JT; Kumar T; Abdulkareem NM; Mao S; Nardone A; Rimawi M; Osborne CK; Lewis MT; Levine H; Zhang B; Schiff R; Giuliano M; Trivedi MV
    J Clin Med; 2019 Oct; 8(11):. PubMed ID: 31652963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative 3' Untranslated Region-Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple-Negative Breast Cancer.
    Wang L; Hu X; Wang P; Shao ZM
    Oncologist; 2019 Jan; 24(1):22-30. PubMed ID: 30082491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy.
    Qian J; Chen H; Ji X; Eisenberg R; Chakravarthy AB; Mayer IA; Massion PP
    Sci Rep; 2017 Apr; 7():45828. PubMed ID: 28387221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
    Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
    Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.
    Apaya MK; Shiau JY; Liao GS; Liang YJ; Chen CW; Yang HC; Chu CH; Yu JC; Shyur LF
    J Exp Clin Cancer Res; 2019 May; 38(1):187. PubMed ID: 31072371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis.
    Chien ST; Yang TF; Yang MC; Hsu CM; Hong YR; Lee TM
    Oncol Rep; 2015 Aug; 34(2):961-71. PubMed ID: 26082034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications.
    Millis SZ; Gatalica Z; Winkler J; Vranic S; Kimbrough J; Reddy S; O'Shaughnessy JA
    Clin Breast Cancer; 2015 Dec; 15(6):473-481.e3. PubMed ID: 26051240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 90-gene signature assay for tissue origin diagnosis of brain metastases.
    Zheng Y; Ding Y; Wang Q; Sun Y; Teng X; Gao Q; Zhong W; Lou X; Xiao C; Chen C; Xu Q; Xu N
    J Transl Med; 2019 Oct; 17(1):331. PubMed ID: 31570099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
    Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
    Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.
    Zhao B; Xu Y; Zhao Y; Shen S; Sun Q
    Front Oncol; 2020; 10():856. PubMed ID: 32596149
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expression and significance of Nek2B and β-catenin in triple negative breast cancer].
    Yan WP; Shen HH; Ma WX; Wang ZY; Shang LF; Shen NN; Qi GY; Wei R; Zhang XQ; Wang C
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):424-429. PubMed ID: 32392924
    [No Abstract]   [Full Text] [Related]  

  • 20. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.